and others had previously suggested that functioning thyroid tissue is necessary in the pathogenesis of progressive exophthalmos and probably for the presence of long acting thyroid stimulator (LATS). Despite previous reports and our personal experience that total thyroid ablation, whether by surgery or by radioactive iodine, has no effect on established exophthalmos, total thyroid ablation can be justified on theoretical grounds since some observers have found significantly higher levels of LATS in thyrotoxic patients with the eye signs of Graves' disease than in those without eye complications; in view of this, and taking into account the enthusiastic early reports on the effect of total thyroid ablation in reducing exophthalmos, we instituted a pilot study to assess the immediate and long-term effects of the therapy.
We selected 9 patients for total thyroid ablation with radioactive iodine. The patients selected had all been initially hyperthyroid and had thyroid disease for varying lengths of time (Table 1) . There were 7 women and 2 men. The ages ranged from 39 to 57 years. They all had bilateral exophthalmos and the duration of exophthalmos in the first eye involved ranged from five months to twenty years. As this was undertaken as a pilot study, a range of patients was selected: at the same time the Medical Research Council was conducting a controlled trial into the treatment of the exophthalmos of thyrotoxicosis by total 11 783 (Boyle et al. 1969 ).
All patients were given ablative doses of ""'I in 1966 and this was repeated where necessary to produce complete ablation. Thyroid scans were made after treatment and these were subsequently repeated during follow up. These scans showed complete thyroid ablation in 6 patients and minimal uptake (3 % or less) in 3 patients.
Results: These 9 patients have been followed for three years. Conclusion: We concluded from this study that total thyroid ablation with radioactive iodine has no effect on established exophthalmos and that such established exophthalmos is static rather than dynamic (Rundle & Wilson 1945) and is not likely to be influenced by any systemic therapy directed at the thyroid gland. Boyle et al. (1969) reported a controlled trial in which two patients had total thyroid ablation with radioactive iodine and they found that this was not in the short term a useful therapy for the eye signs of Graves' disease. In our patients there was no significant change in exophthalmos or in the other eye signs of Graves' (Elsby 1968) after modifying it to be used with a haptic contact lens which could take the weighted plunger and could be used on the eye after instilling a topical anmesthetic. The graph produced in a series of patients with this instrument is shown in Fig 1. For routine purposes it was found that only the 100 g weight need be used (Table 2) . Eighteen patients with chronic dysthyroid infiltration were selected. There were 15 women and 3 men, age range 34-69 years. All patients had been hyperthyroid but were euthyroid or euthyroid on treatment, and all had bilateral orbital infiltration but no other eye disease. They all had raised orbital pressure, conjunctival injection and pain in the orbital region; five patients had ophthalmoplegia. The orbital pressures were assessed by orbitonometry before treatment, at the conclusion of treatment and three months after the conclusion of treatment using the instrument described by Elsby (1968) . One orbit was selected at random for treatment and the other was taken as control. Triamcinolone acetonide was used for injection as we have found this to be the most effective of the available injectable corticosteroids in dealing with orbital lesions.
The patients were admitted to hospital for treatment. Triamcinolone acetonide, 1mg in lml, was injected into the orbit on the side to be treated. This was repeated, selecting different parts of the orbit for injection on each occasion, until the series of injections was completed. The minimum number of injections was five; no patient had more than ten injections.
Results: There was an increase in orbital pressure following each injection but this disappeared within a few days of the conclusion of treatment.
E2. At the end of three months the orbitonometer readings were improved in all but 2 patients and the mean improvement showed a significant change as compared with the control eyes (Fig 2) . There was symptomatic improvement with reduction of pain on the treated side in 14 patients, no change in 3 patients and an increase in pain in 1 patient. 
